Xin Su
Impact in
-
- Cardiac Ischemia and Reperfusion
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
-
- Antimicrobial Resistance in Staphylococcus 2
- Tuberculosis Research and Epidemiology 2
- Co-authors
- Yanwei Xing (15 shared papers)Fan Yang (10 shared papers)Xinye Li (5 shared papers)Ning Ma (2 shared papers)Lijing Zhang (1 shared paper)Yanchi Zhang (1 shared paper)Yanfen Xing (2 shared papers)Pan Yang (1 shared paper)
- Journals
- Oxidative Medicine and Cellular Longevity (5 papers)Frontiers in Cardiovascular Medicine (5 papers)Pharmacological Research (2 papers)Biomedicine & Pharmacotherapy (2 papers)Emerging Microbes & Infections (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xin Su
37 papers receiving 623 citations
Peers
Comparison fields: 5 of 72
- Aging 14
- Pathology and Forensic Medicine 77
- Complementary and alternative medicine 43
- Pulmonary and Respiratory Medicine 117
- Drug Discovery 1
Countries citing papers authored by Xin Su
This map shows the geographic impact of Xin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Su more than expected).
Fields of papers citing papers by Xin Su
This network shows the impact of papers produced by Xin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Su. The network helps show where Xin Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 171 | |
| 2 | 2021 | 41 | |
| 3 | 2023 | 38 | |
| 4 | 2021 | 37 | |
| 5 | 2019 | 33 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 31 | |
| 8 | 2019 | 27 | |
| 9 | 2022 | 22 | |
| 10 | CircularRNA circPARP4 promotes glioblastoma progression through sponging miR-125a-5p and regulating FUT4. | 2021 | 19 |
| 11 | 2021 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 16 | |
| 15 | MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2. | 2015 | 13 |
| 16 | 2016 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 2019 | 9 | |
| 20 | 2022 | 9 |
About Xin Su
Xin Su is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Molecular Biology, Pathology and Forensic Medicine and Nephrology, having authored 38 papers that have together received 636 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Cardiac Ischemia and Reperfusion (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Saffron Plant Research Studies (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Tuberculosis Research and Epidemiology (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Aging (14 citations), Pathology and Forensic Medicine (77 citations), Complementary and alternative medicine (43 citations), Pulmonary and Respiratory Medicine (117 citations) and Drug Discovery (1 citation). Xin Su has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yanwei Xing, Fan Yang, Xinye Li, Ning Ma, Lijing Zhang, Yanchi Zhang, Yanfen Xing, Pan Yang, Na An and Can Liu. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Frontiers in Cardiovascular Medicine, Pharmacological Research, Biomedicine & Pharmacotherapy and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.